The assumption
A “research use only” label makes an offer for treatment acceptable.
What the answer rests on
“Research use only” presents a product as meant for laboratory work, not for people to take. As of September 2026, FDA, the Food and Drug Administration, says that wording does not excuse an offer intended to treat people. In warning letters, FDA pointed to treatment claims and water sold to mix products for injection as evidence that sellers intended people to use them.
Signs of an unreliable seller
Some gaps have a direct answer
FDA means the Food and Drug Administration. Federal law as of September 2026 prohibits supplying a prescription medicine without a valid prescription.
As of September 2026, calling a compounded drug FDA-approved is false. Compounded drugs are made to order and do not have FDA product approval.
FDA’s checklist also flags the lack of a licensed doctor to answer questions after delivery, packaging damage, and false details about a pharmacy.
The agency has found fraudulent compounded semaglutide and tirzepatide bearing the names of pharmacies that do not exist, or that did not make the products.
The short version
Keep the missing question visible
| The offer says | Ask for the missing detail |
|---|---|
| The results are assured. | What evidence supports the claim, and what are its limits? |
| The pharmacy is registered. | Which state licence covers this pharmacy? |
| The price is much lower. | What exact product and full set of fees does that price cover? |
| The form gets me started. | Who reviews it and answers my own questions? |
Where Illinois hears concerns
Chicago concerns have public routes
In its January 2025 alert, the Illinois Attorney General flagged misleading weight medicine ads, research-only products, and requests to misstate weight. Its comments about shortages describe January 2025, before the shortages ended. Use the alert’s signs of misleading advertising, but check the current rules for copies on the made-to-order drugs page.
IDFPR, Illinois’s Department of Financial and Professional Regulation, takes complaints about the professionals and pharmacies it regulates.
The Illinois Attorney General takes complaints about deception. Its Health Care Bureau can help with billing, coverage disputes, and misleading health ads; it cannot be a person’s private lawyer.
Keep the wording of the offer, the product name, and the payment record together. They give you concrete details to include when describing a concern.
Separate the offer from its proof
Which part of this offer can I verify, and which part is still just a claim?
Keep a question in your notesEvidence for this chapter
Chapter notes
- FDA: concerns and consumer checks
Research labels, false pharmacy details, and follow-up gaps.
- FDA: misleading product claims
What approval and sameness claims leave out.
- Illinois Attorney General: the earlier alert
The state consumer alert and its historical context.
- IDFPR: file a professional complaint
The state’s route for regulated professionals and pharmacies.
- Illinois Attorney General: health care disputes
Help with billing, coverage, and misleading advertising.